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Letters to the Editors
Platelet monolayer formation in the solid-
phase red cell adherence method using fresh
frozen plasma
A rapid and simple solid phase red cell adherence
(SPRCA) technique for platelet antibody screening has
been previously described using antithrombocyte globu-
lin (ATG) to bind platelets to microtiter wells and form a
stable platelet monolayer.1,2 Because ATG (DAKO,
Denmark) is no longer available, an alternative platelet
binding method has been established. We have made a
simple modification to the original ATG SPRCA method
by diluting group O platelet-rich plasma in inert group O
expired fresh frozen plasma (FFP) to give a final platelet
concentration of 50–60 × 109L–1. Microtiter wells
(NUNC,Denmark) were treated with 200 µL of methanol
(BDH, Merck, Australia) for 5 minutes and dried. Fifty
microliters of diluted platelets were added to each
microtiter well and the microtiter plate was centrifuged
at 150 g for 3 minutes,followed by incubation at 37°C for
15 minutes.Thereafter, the modified SPRCA method fol-
lowed the method described earlier for the ATG SPRCA
method.2 Excess nonadhered platelets were removed by
washing × 3 with 200 µL of 0.2% bovine serum albumin
in phosphate-buffered saline (0.2% BSA/PBS), then 50 µL
of serum and 100 µL of 1.9% glycine were added, fol-
lowed by incubation at 37°C for 15 minutes.The plates
were washed × 4 with 200 µL of 0.2% BSA/PBS, then 50
µL of anti-human globulin (CSL,Australia) and 50 µL of
0.6% antiglobulin control cells (CSL) diluted in Celpresol
(CSL) were added. The microplates were then cen-
trifuged at 90 g for 2 minutes.Presence or absence of red
cell effacement was observed for result determination.
We compared the results of the modified SPRCA
with that of the original method to ensure adequate
platelet binding and appropriate test results. Thirty-
nine sera containing known platelet antibodies were
tested including 30 anti-HLA, 3 anti-HPA-1a, 1 anti-HPA-
3a, 1 anti-HPA-5a, and 4 quinine-associated antibodies.
These known platelet antibodies had been identified
previously using a monoclonal antibody immobiliza-
tion of platelet antigen (MAIPA) technique. In addition,
28 unknown sera from bone marrow transplant (BMT)
recipients were examined.
Identical results were obtained by the two platelet-
binding methods,with the exception of one known HLA
antibody found positive only by the modified SPRCA. All
28 BMT sera were found to be negative by both binding
methods.
Titers of seven platelet antibodies were determined,
including two HPA-1a antibodies and five HLA antibod-
ies.The seven platelet antibodies had titers from 1 to 32.
The titers of three antibodies were found to be the same
by both platelet-binding methods.The titer of one anti-
body was twofold higher by ATG SPRCA, whereas the
remaining three platelet antibodies were twofold higher
by the modified SPRCA method.
The results obtained were comparable for the two
platelet-binding methods both in the ability to detect
positive and negative sera and the titer of the antibodies.
The strength of red cell effacement for the positive reac-
tions was also found to be concordant.The performance
time was identical for both assays.
In conclusion, FFP is an inexpensive and simple alter-
native to ATG for performance of the SPRCA method.
The effective platelet binding in this modified method
may be associated with adherence of fibrinogen, albu-
min, or other plasma proteins present in FFP between
the platelets and the microtiter well.3
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